1-4 of 4
Florence Hourcade-Potelleret
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Population Pharmacokinetics in Hepatic and Renal Impairment and PBPK Drug-Drug Interaction Simulations of Asciminib, a Novel Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia in Chronic Phase

Matthias Hoch, Felix Huth, Ioannis Loisios Konstantinidis, Huijuan Xu, Yu-Yun Ho, Francois Pierre Combes, Florence Hourcade-Potelleret, Heidi J Einolf
Journal: Blood
Blood (2022) 140 (Supplement 1): 6771–6773.
https://doi.org/10.1182/blood-2022-163167
Published: 2022
Journal Articles

Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia

Clinical Trials & Observations
Nobuko Hijiya, Alexey Maschan, Carmelo Rizzari, Hiroyuki Shimada, Carlo Dufour, Hiroaki Goto, Hyoung Jin Kang, Terri Guinipero, Zeynep Karakas, Francisco Bautista, Stéphane Ducassou, Keon Hee Yoo, Christian Michel Zwaan, Frédéric Millot, Paola Aimone, Alex Allepuz, Sara Quenet, Florence Hourcade-Potelleret, Sabine Hertle, Darintr Sosothikul
Journal: Blood
Blood (2019) 134 (23): 2036–2045.
https://doi.org/10.1182/blood.2019000069
Published: 2019
Includes: Supplemental data
Journal Articles

Subcutaneous Rituximab in Combination with Fludarabine and Cyclophosphamide for Patients with CLL: Initial Results of a Phase Ib Study (SAWYER [BO25341]) Show Non-Inferior Pharmacokinetics and Comparable Safety to That of Intravenous Rituximab

Sarit Assouline, Valeria Buccheri, MD; PhD., Alain Delmer, MD, Gottfried Doelken, MD, Gianluca Gaidano, MD, PhD, Christine McIntyre, Mike Brewster, Florence Hourcade-Potelleret, PhD, Pakeeza Sayyed, Xavier Badoux, MB BS FRACP FRCPA
Journal: Blood
Blood (2012) 120 (21): 1637.
https://doi.org/10.1182/blood.V120.21.1637.1637
Published: 2012
Journal Articles

Pharmacokinetics of Obinutuzumab (GA101) in Patients with CD20+ Relapsed/Refractory Malignant Disease Receiving Concomitant Chemotherapy (Phase Ib Study BO21000),

David Carlile, PhD, Georgina Meneses-Lorente, PhD, Elisabeth Wassner-Fritsch, Florence Hourcade-Potelleret, PhD, Michael K. Wenger, Guillaume Cartron, MD, PhD, Umberto Vitolo, MD, John Radford, MD, Andrew Davies, Franck Morschhauser, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3704.
https://doi.org/10.1182/blood.V118.21.3704.3704
Published: 2011